Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vogl

Showing results (201-210 of 334) with videos related to

Pageof 34
Sort By:
Elife|November 28, 2025
The SAFE Labs Handbook as a tool for improving lab cultureErika Donà, James M Gahan, Petrina Lau, et al.
Arthritis Research & Therapy|August 20, 2021
S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout miceIrene Di Ceglie, Peter L E M van Lent, Edwin J W Geven, et al.
Nature Communications|October 4, 2024
Postnatal supplementation with alarmins S100a8/a9 ameliorates malnutrition-induced neonate enteropathy in miceLisa Perruzza, Julia Heckmann, Tanja Rezzonico Jost, et al.
Carcinogenesis|August 12, 2008
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisOlga Turovskaya, Dirk Foell, Pratima Sinha, et al.
Theranostics|June 20, 2020
Targeting of Formyl Peptide Receptor 2 for <i>in vivo</i> imaging of acute vascular inflammationTamara Boltersdorf, Junaid Ansari, Elena Y Senchenkova, et al.
Journal of Cancer|March 26, 2014
Cone Beam Computertomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime NavigationWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Thomas Vogl, et al.
Cell Reports|August 23, 2023
S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritisMeike von Wulffen, Veronika Luehrmann, Stefanie Robeck, et al.
Frontiers in Immunology|July 5, 2021
S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease DevelopmentLaura M Davison, Andres A Alberto, Hardik A Dand, et al.
Oncoimmunology|December 15, 2018
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cellsJulia Krombach, Roman Hennel, Nikko Brix, et al.
Nature Communications|October 11, 2022
S100A8-mediated metabolic adaptation controls HIV-1 persistence in macrophages in vivoFernando Real, Aiwei Zhu, Boxin Huang, et al.
Pageof 34

Showing results (201-210 of 334) with videos related to

Sort By:
Pageof 34
Elife|November 28, 2025
The SAFE Labs Handbook as a tool for improving lab cultureErika Donà, James M Gahan, Petrina Lau, et al.
Arthritis Research & Therapy|August 20, 2021
S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout miceIrene Di Ceglie, Peter L E M van Lent, Edwin J W Geven, et al.
Nature Communications|October 4, 2024
Postnatal supplementation with alarmins S100a8/a9 ameliorates malnutrition-induced neonate enteropathy in miceLisa Perruzza, Julia Heckmann, Tanja Rezzonico Jost, et al.
Carcinogenesis|August 12, 2008
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesisOlga Turovskaya, Dirk Foell, Pratima Sinha, et al.
Theranostics|June 20, 2020
Targeting of Formyl Peptide Receptor 2 for <i>in vivo</i> imaging of acute vascular inflammationTamara Boltersdorf, Junaid Ansari, Elena Y Senchenkova, et al.
Journal of Cancer|March 26, 2014
Cone Beam Computertomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime NavigationWolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Thomas Vogl, et al.
Cell Reports|August 23, 2023
S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritisMeike von Wulffen, Veronika Luehrmann, Stefanie Robeck, et al.
Frontiers in Immunology|July 5, 2021
S100a9 Protects Male Lupus-Prone NZBWF1 Mice From Disease DevelopmentLaura M Davison, Andres A Alberto, Hardik A Dand, et al.
Oncoimmunology|December 15, 2018
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cellsJulia Krombach, Roman Hennel, Nikko Brix, et al.
Nature Communications|October 11, 2022
S100A8-mediated metabolic adaptation controls HIV-1 persistence in macrophages in vivoFernando Real, Aiwei Zhu, Boxin Huang, et al.
Pageof 34